Novo Nordisk Clinical Innovation Centre A/S

CVR 46290003 · Public limited company (A/S) · Active · Medium risk

Novo Nordisk Clinical Innovation Centre A/S is a Public limited company (A/S), founded on , based in Gentofte. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 2.6% over the next 12 months, which is 1.9 times the average for Danish companies.

Bankruptcy risk for Novo Nordisk Clinical Innovation Centre A/S

2.6%
probability of bankruptcy within 12 months
Medium risk

1.9 × the average (1.41%) · higher risk than 86% of active Danish companies

Lowest riskHighest risk

Increases the risk

Published annual reports0 · bankruptcy rate 16.7%1.9×
Time at current address0.5–1 yrs · bankruptcy rate 16.5%1.9×
Age (years)< 1 yrs · bankruptcy rate 12.9%1.5×
Number of CEOs0 · bankruptcy rate 12.7%1.4×
CEOs in total (historical)0 · bankruptcy rate 12.4%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×

Reduces the risk

Company typeA/S · bankruptcy rate 4.4%0.50×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×
Has a boardYes · bankruptcy rate 6.0%0.68×
Number of auditors (historical)1 · bankruptcy rate 6.2%0.70×
Capital changes1 · bankruptcy rate 7.0%0.80×
Moves in the last 2 years0 · bankruptcy rate 7.4%0.84×
Other companies at the same address0 · bankruptcy rate 7.5%0.85×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
46290003
Status
Active
Company type
Public limited company (A/S)
Founded
(0 years)
Address
Niels Steensens Vej 2B
2820 Gentofte
Municipality
Gentofte
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 400k
Auditor
DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
Audit opted out
No

Warning signs

Annual reports filed late0 of 0
Missing annual reportNo
Negative equity–
Equity ratio–
Current ratio–
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address0
Going-concern uncertaintyNo

Management, owners and auditor

RoleNameFromTo
BoardFilip Krag KnopCurrent
BoardJoan Toftegaard BoesenCurrent
BoardMarianne ØlholmCurrent
BoardDesirée Thielke ThyssenCurrent
BoardDesirée Thielke Thyssen
Owner (100%)NOVO NORDISK REGION EUROPE A/SCurrent
AuditorDELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKABCurrent
FounderNOVO NORDISK REGION EUROPE A/SCurrent

Address history (0 moves)

Niels Steensens Vej 2B, 2820 Gentofte

Similar companies in Gentofte

Questions and answers about Novo Nordisk Clinical Innovation Centre A/S

Has Novo Nordisk Clinical Innovation Centre A/S gone bankrupt?

No, Novo Nordisk Clinical Innovation Centre A/S is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Novo Nordisk Clinical Innovation Centre A/S?

Our model estimates a bankruptcy risk of 2.6% over the next 12 months (medium risk), which is 1.9 times the average for Danish companies.

Who is the auditor of Novo Nordisk Clinical Innovation Centre A/S?

Novo Nordisk Clinical Innovation Centre A/S most recently used DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB.

When was Novo Nordisk Clinical Innovation Centre A/S founded?

Novo Nordisk Clinical Innovation Centre A/S was founded on 26 February 2026.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.